Snyder has more than 17 years of experience in life sciences. He joined Navigant in 2014 and focuses on optimizing strategy for pharmaceutical and biotech companies, including assessing business development opportunities, valuing new technology, and developing plans to maximize the value of assets and portfolios. Recent work has spanned such conditions as Alzheimer’s, Parkinson’s, and spinal cord injuries; oncology; virology; and such rare diseases as cystic fibrosis and progressive supranuclear palsy. Snyder began his consulting career at McKinsey & Company, supporting global leaders in pharmaceutical and medical devices. His work included launch support of an Alzheimer’s disease therapeutic and diligence on a $20 billion acquisition in medical devices.